Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Witte

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 21, 2006
Differential CNS expression and functional activity of multiple human H(3) receptor isoformsT A Esbenshade, M I Strakhova, T L Carr, et al.
Journal of Medicinal Chemistry|May 29, 1992
Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residuesK Shiosaki, C W Lin, H Kopecka, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 18, 2006
Differences in pharmacological properties of histamine H(3) receptor agonists and antagonists revealed at two human H (3) receptor isoformsT A Esbenshade, K M Krueger, B B Yao, et al.
Journal of Receptor and Signal Transduction Research|April 12, 2003
Differential activation of dual signaling responses by human H1 and H2 histamine receptorsTimothy A Esbenshade, Chae Hee Kang, Kathleen M Krueger, et al.
Journal of Medicinal Chemistry|January 1, 1991
trans-3-n-propyl-L-proline is a highly favorable, conformationally restricted replacement for methionine in the C-terminal tetrapeptide of cholecystokinin. Stereoselective synthesis of 3-allyl- and 3-n-propyl-L-proline derivatives from 4-hydroxy-L-prolineM W Holladay, C W Lin, C S May, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2016
Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective CohortsRuud C Wortel, Luca Incrocci, Floris J Pos, et al.
The American Journal of Physiology|April 1, 1990
A71378: a CCK agonist with high potency and selectivity for CCK-A receptorsC W Lin, M W Holladay, D G Witte, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 3, 2015
Dose-surface maps identifying local dose-effects for acute gastrointestinal toxicity after radiotherapy for prostate cancerRuud C Wortel, Marnix G Witte, Uulke A van der Heide, et al.
International Journal of Radiation Oncology, Biology, Physics|March 11, 2015
Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patientsRuud C Wortel, Luca Incrocci, Floris J Pos, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 12, 2005
G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformationsKathleen M Krueger, David G Witte, Lynne Ireland-Denny, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 21, 2006
Differential CNS expression and functional activity of multiple human H(3) receptor isoformsT A Esbenshade, M I Strakhova, T L Carr, et al.
Journal of Medicinal Chemistry|May 29, 1992
Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residuesK Shiosaki, C W Lin, H Kopecka, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 18, 2006
Differences in pharmacological properties of histamine H(3) receptor agonists and antagonists revealed at two human H (3) receptor isoformsT A Esbenshade, K M Krueger, B B Yao, et al.
Journal of Receptor and Signal Transduction Research|April 12, 2003
Differential activation of dual signaling responses by human H1 and H2 histamine receptorsTimothy A Esbenshade, Chae Hee Kang, Kathleen M Krueger, et al.
Journal of Medicinal Chemistry|January 1, 1991
trans-3-n-propyl-L-proline is a highly favorable, conformationally restricted replacement for methionine in the C-terminal tetrapeptide of cholecystokinin. Stereoselective synthesis of 3-allyl- and 3-n-propyl-L-proline derivatives from 4-hydroxy-L-prolineM W Holladay, C W Lin, C S May, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2016
Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective CohortsRuud C Wortel, Luca Incrocci, Floris J Pos, et al.
The American Journal of Physiology|April 1, 1990
A71378: a CCK agonist with high potency and selectivity for CCK-A receptorsC W Lin, M W Holladay, D G Witte, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 3, 2015
Dose-surface maps identifying local dose-effects for acute gastrointestinal toxicity after radiotherapy for prostate cancerRuud C Wortel, Marnix G Witte, Uulke A van der Heide, et al.
International Journal of Radiation Oncology, Biology, Physics|March 11, 2015
Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patientsRuud C Wortel, Luca Incrocci, Floris J Pos, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 12, 2005
G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformationsKathleen M Krueger, David G Witte, Lynne Ireland-Denny, et al.
Pageof 16